These novel therapies , Retatrutide, represent a remarkable advancement in managing type 2 diabetes and possibly related conditions . They are grouped as GLP-1 hormone activators , indicating they function to mimic the natural GLP-1 substance , boosting metabolic release and suppressing appetite . Although Tirzepatide each one operates relatively s